The Best Quantum Computing Stock to Buy Now: D-Wave Quantum vs. Rigetti Computing

Key events: D-Wave announced early system sales including a $20.0M system to Florida Atlantic University and a €10.0M (≈$11.5M) booking in Italy, while Rigetti's notable sale was $8.4M in Q4 to an India client and Rigetti was eliminated in phase one of a DARPA contract bid. The analyst scores three categories (technology approach, financials, partnerships): Rigetti wins on broader superconducting potential, but D-Wave wins on financials and partnerships, giving it a 2-1 overall edge. Conclusion: the author recommends D-Wave as the better buy today due to healthier revenue bookings and existing manufacturing partnerships despite its specialized (annealing) focus.

Analysis

Specialization in quantum hardware compresses TAM but can increase near-term revenue durability: verticalized annealing boxes sell into repeatable workflows (scheduling, logistics, inference tuning) where sticky software and domain datasets create switching costs that classical incumbents struggle to replicate. Conversely, general-purpose superconducting architectures carry optionality but also materially higher capital and integration risk — that widens variance in funding outcomes and makes equity paths to break-even longer and more dilution-prone.

Second-order winners include industrial software vendors, cloud integrators, and fabs that can bundle optimization appliances into recurring-service agreements; these partners will capture most of the gross margin unless the hardware vendor locks in the stack. Expect supply-chain bifurcation: annealing hardware pushes demand to automation and systems integrators, while superconducting pushes to cryogenics, microwave controls, and chip-foundry scale — each has different capex and cycle-time profiles that influence partner bargaining power.

Key catalysts are enterprise-scale subscription deals, third-party benchmark wins, and defense/agency procurement decisions that de-risk long-cycle revenue forecasts; these play out over 6–24 months. Tail risks include rapid classical algorithmic improvements that erase near-term edge, a funding shock that selectively penalizes high-capex models within 12 months, or a marquee partner flip that reallocates integration economics away from the hardware vendor.

The consensus framing underprices acquisition optionality for proven vertical players and overprices optionality for broad-platform bets. That asymmetry creates a win-favoring payoff for concentrated, time-limited exposure to specialized vendors while hedging against the asymmetric dilution and technical risk of general-purpose players.

Key Decisions for Investors

• Pair trade (6–18 months): Long QBTS equity sized 1.5% NAV and short RGTI equal-dollar 1.5% NAV. Rationale: capture divergence between specialization-driven recurring revenue and capital-intense platform risk. Risk management: tighten to 25% stop on either leg; target net return ~+150–300% if thesis materializes.
• Defined-risk options (9–15 months): Buy QBTS 9–15 month call spread (near-the-money long, sell 1.5x strike) size 0.5% NAV to limit premium spend while keeping convex upside to enterprise booking beats. Max loss = premium; upside capped but provides ~3:1+ payoff if stock doubles.
• Hedge against capex/funding shock (6–12 months): Buy RGTI 6–9 month put spread to cap downside exposure (size 0.5% NAV). This limits tail risk from dilution or missed benchmarks while preserving capital to reallocate on objective weakness.
• Convexity kicker (12–24 months): Small long NVDA call position (0.5% NAV in LEAPs or call spread) as an uncorrelated hedge to broader AI acceleration and potential QPU-to-GPU workflow partnerships. Expect asymmetric upside if cross-sell to AI stacks materializes; cap exposure to limit drawdown.